COMPANY PROFILE // THE 014 REPORT
Utah Medical Products Inc.
UTMD (Nasdaq)
Assembled from 4 government sources in 2.5 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberLEI 5493002R27BBGV8DID60 registration status is LAPSED (last update 2023-08-04): the legal-entity record has not been renewed.
✓ SEC filings✓ LEI✓ State registrationpossible match✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No SAM registration, no IRS return, no website, no lobbying registration on record.
UTAH MEDICAL PRODUCTS INC is an SEC-registered operating company in surgical & medical instruments & apparatus, incorporated in UT, based in Midvale, UT; listed as UTMD (Nasdaq).[source] It reported revenue of $38.5 million for the fiscal year ended 2025-12-31.[source] It has filed 29 documents with the SEC in the last 12 months; the latest is Form 10-Q, filed 2026-11-13.[source] Its largest institutional holders on 13F filings are BRANDES INVESTMENT PARTNERS, LP, BlackRock, Inc., DIMENSIONAL FUND ADVISORS LP (as of 2026-06-30).[source] Seraphix flags 1 item from these records: LEI 5493002R27BBGV8DID60 registration status is LAPSED (last update 2023-08-04).[source]
- red0
- amber1
- info0
- BRANDES INVESTMENT PARTNERS, LP$32.8M
- BlackRock, Inc.$14.1M
- DIMENSIONAL FUND ADVISORS LP$13.7M
- RENAISSANCE TECHNOLOGIES LLC$12.1M
- VANGUARD CAPITAL MANAGEMENT LLC$9.3M
- GEODE CAPITAL MANAGEMENT, LLC$7.5M
- Minerva Advisors LLC$6.5M
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC$5.9M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Koopman Brian · Principal Financial Officer (Officer) · latest Form 4 2025-11-25 · filing · LinkedIn search
- RICHINS PAUL O · Director · latest Form 4 2025-08-26 · filing · LinkedIn search
- Timken Kevin · Director · latest Form 3 2025-12-18 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0000706698 | source |
| LEI | 5493002R27BBGV8DID60 | source |
| EIN | 87-0342734 | source |
| Business address (SEC) | 7043 S 300 WEST, MIDVALE, UT, 84070 | source |
Does not exist in the records we hold: UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2016-02-11 · in -3,937 days · LEI next renewal (5493002R27BBGV8DID60)
- 2027-03-31 · in 129 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 174 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-03 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-10-29 filing SC TO-I/A · SEC EDGAR
- 2026-10-22 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-10-05 filing SC TO-I/A · SEC EDGAR
- 2026-09-29 filing SC TO-I/A · SEC EDGAR
- 2026-09-25 filing SC TO-C · SEC EDGAR
- 2026-09-24 filing SC TO-C · SEC EDGAR
- 2026-09-24 filing SC TO-I · SEC EDGAR
- 2026-09-17 filing SC TO-C · SEC EDGAR
- 2026-08-31 filing 8-K items 7.01 · SEC EDGAR
- 2026-08-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-07-23 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-05-27 filing SD · SEC EDGAR
- 2026-05-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-04 filing 8-K items 5.07 · SEC EDGAR
- 2026-04-23 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-02 filing Proxy statement · SEC EDGAR
- 2026-03-27 filing Annual report (10-K) · SEC EDGAR
- 2026-01-29 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-12-18 insider First Form 3/4/5 on record for Timken Kevin (Director) · SEC Forms 3/4/5
- 2025-11-14 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-04 officer change 8-K items 5.02,8.01,9.01 · SEC EDGAR
- 2025-10-23 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-09-05 insider First Form 3/4/5 on record for Koopman Brian (Principal Financial Officer) · SEC Forms 3/4/5
- 2025-08-26 insider First Form 3/4/5 on record for RICHINS PAUL O (Director) · SEC Forms 3/4/5
- 2025-08-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-07-24 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-05-28 filing SD · SEC EDGAR
- 2025-05-15 filing Quarterly report (10-Q) · SEC EDGAR
170 earlier entries
- 2025-05-05 filing 8-K items 5.07
- 2025-04-29 filing 8-K items 2.02,9.01
- 2025-04-04 filing Proxy statement
- 2025-03-26 filing Annual report (10-K)
- 2025-01-28 filing 8-K items 2.02,9.01
- 2024-11-12 filing Quarterly report (10-Q)
- 2024-11-05 officer change 8-K items 5.02,8.01,9.01
- 2024-10-29 filing 8-K items 2.02,9.01
- 2024-08-09 filing Quarterly report (10-Q)
- 2024-07-25 filing 8-K items 2.01,9.01
- 2024-05-31 filing SD
- 2024-05-10 filing Quarterly report (10-Q)
- 2024-05-06 filing 8-K items 5.07
- 2024-04-25 filing 8-K items 2.01,9.01
- 2024-04-15 filing DEFA14A
- 2024-04-10 filing Proxy statement
- 2024-03-26 filing Annual report (10-K)
- 2024-01-30 filing 8-K items 2.02,9.01
- 2023-11-13 filing Quarterly report (10-Q)
- 2023-10-31 filing 8-K items 8.01,9.01
- 2023-10-26 filing 8-K items 2.02,9.01
- 2023-08-11 filing Quarterly report (10-Q)
- 2023-07-25 filing 8-K items 2.02,9.01
- 2023-07-14 filing S-8
- 2023-06-14 filing 144
- 2023-05-30 filing SD
- 2023-05-18 filing 144
- 2023-05-08 filing 8-K items 5.07
- 2023-05-05 filing Quarterly report (10-Q)
- 2023-04-25 filing 8-K items 2.02,9.01
- 2023-04-12 filing DEFA14A
- 2023-04-04 filing Proxy statement
- 2023-03-28 filing 10-K/A
- 2023-03-27 filing Annual report (10-K)
- 2023-01-31 filing 8-K items 2.02,9.01
- 2022-11-10 filing Quarterly report (10-Q)
- 2022-11-01 filing 8-K items 8.01,9.01
- 2022-10-25 filing 8-K items 2.02,9.01
- 2022-08-12 filing Quarterly report (10-Q)
- 2022-07-28 filing 8-K items 2.02,9.01
- 2022-05-31 filing SD
- 2022-05-11 filing Quarterly report (10-Q)
- 2022-05-09 filing 8-K items 5.07
- 2022-04-27 filing 8-K items 2.02,9.01
- 2022-04-13 filing Proxy statement
- 2022-03-25 filing Annual report (10-K)
- 2022-02-08 filing 8-K items 8.01,9.01
- 2022-02-02 filing 8-K items 2.02,9.01
- 2021-11-12 filing Quarterly report (10-Q)
- 2021-11-02 filing 8-K items 8.01,9.01
- 2021-10-26 filing 8-K items 2.02,9.01
- 2021-08-06 filing Quarterly report (10-Q)
- 2021-07-22 filing 8-K items 2.02,9.01
- 2021-05-26 filing SD
- 2021-05-11 filing Quarterly report (10-Q)
- 2021-05-07 filing 8-K items 5.07
- 2021-04-23 filing 8-K items 2.02,9.01
- 2021-04-12 filing Proxy statement
- 2021-03-26 filing Annual report (10-K)
- 2021-03-01 filing 8-K items 1.02
- 2021-01-28 filing 8-K items 2.02,9.01
- 2020-11-09 filing 10-Q/A
- 2020-11-06 filing Quarterly report (10-Q)
- 2020-11-03 filing 8-K items 8.01,9.01
- 2020-10-27 filing 8-K items 2.02,9.01
- 2020-08-10 filing 8-K items 5.07
- 2020-08-07 filing Quarterly report (10-Q)
- 2020-07-28 filing 8-K items 2.02,9.01
- 2020-07-14 filing Proxy statement
- 2020-05-29 filing SD
- 2020-05-08 filing Quarterly report (10-Q)
- 2020-04-23 filing 8-K items 2.02
- 2020-03-31 filing 10-K/A
- 2020-03-24 filing 8-K items 8.01,9.01
- 2020-03-16 filing Annual report (10-K)
- 2020-01-30 filing 8-K items 2.02,9.01
- 2019-11-07 filing Quarterly report (10-Q)
- 2019-11-05 filing 8-K items 8.01,9.01
- 2019-10-24 filing 8-K items 2.02,9.01
- 2019-09-13 filing UPLOAD
- 2019-09-10 filing CORRESP
- 2019-09-10 filing UPLOAD
- 2019-08-09 filing Quarterly report (10-Q)
- 2019-07-30 filing 8-K items 2.02,9.01
- 2019-05-31 filing SD
- 2019-05-09 filing Quarterly report (10-Q)
- 2019-05-06 filing 8-K items 5.07
- 2019-04-25 filing 8-K items 2.02,9.01
- 2019-04-05 filing Proxy statement
- 2019-03-14 filing Annual report (10-K)
- 2019-02-13 filing 8-K items 2.01,9.01
- 2019-01-31 filing 8-K items 2.02,9.01
- 2019-01-07 filing 8-K items 1.01,9.01
- 2018-11-16 filing 8-K items 4.01,9.01
- 2018-11-07 filing Quarterly report (10-Q)
- 2018-10-30 filing 8-K items 8.01,9.01
- 2018-10-23 filing 8-K items 2.02,9.01
- 2018-10-18 filing 8-K items 2.02,9.01
- 2018-08-09 filing Quarterly report (10-Q)
- 2018-05-31 filing SD
- 2018-05-09 filing Quarterly report (10-Q)
- 2018-05-08 filing 8-K items 5.07
- 2018-04-26 filing 8-K items 2.02,9.01
- 2018-04-09 filing PX14A6G
- 2018-04-02 officer change 8-K items 5.02
- 2018-03-08 filing Proxy statement
- 2018-03-06 filing Annual report (10-K)
- 2018-01-30 filing 8-K items 2.02,9.01
- 2017-11-07 filing Quarterly report (10-Q)
- 2017-10-31 filing 8-K items 8.01,9.01
- 2017-10-24 filing 8-K items 2.02,9.01
- 2017-08-03 filing Quarterly report (10-Q)
- 2017-07-25 filing 8-K items 2.02,9.01
- 2017-05-31 filing SD
- 2017-05-08 filing 8-K items 5.07
- 2017-05-05 filing Quarterly report (10-Q)
- 2017-04-25 filing 8-K items 2.02,9.01
- 2017-03-10 filing Proxy statement
- 2017-03-08 filing Annual report (10-K)
- 2017-01-31 filing 8-K items 2.02
- 2016-11-04 filing Quarterly report (10-Q)
- 2016-11-01 filing 8-K items 8.01,9.01
- 2016-10-26 filing 8-K items 2.02,9.01
- 2016-08-08 filing Quarterly report (10-Q)
- 2016-07-26 filing 8-K items 2.02,9.01
- 2016-07-26 filing 8-K items 2.02,9.01
- 2016-07-26 filing 8-K items 2.02,9.01
- 2016-05-31 filing SD
- 2016-05-06 filing Quarterly report (10-Q)
- 2016-05-02 filing 8-K items 5.07
- 2016-04-26 filing 8-K items 2.02,9.01
- 2016-03-10 filing Annual report (10-K)
- 2016-03-10 filing Proxy statement
- 2016-02-02 filing 8-K items 2.02
- 2015-12-16 filing CORRESP
- 2015-12-03 filing UPLOAD
- 2015-11-06 filing Quarterly report (10-Q)
- 2015-11-03 filing 8-K items 8.01,9.01
- 2015-10-22 filing 8-K items 2.02,9.01
- 2015-08-07 filing Quarterly report (10-Q)
- 2015-07-23 filing 8-K items 2.02,9.01
- 2015-06-01 filing SD
- 2015-05-06 filing Quarterly report (10-Q)
- 2015-05-04 filing 8-K items 5.07
- 2015-04-23 filing 8-K items 2.02,9.01
- 2015-03-12 filing Proxy statement
- 2015-03-12 filing Annual report (10-K)
- 2015-01-29 filing 8-K items 2.02
- 2014-11-04 filing Quarterly report (10-Q)
- 2014-11-04 filing 8-K items 8.01,9.01
- 2014-11-04 filing 8-K items 1.01
- 2014-10-24 filing 8-K items 1.01
- 2014-10-23 filing 8-K items 2.02
- 2014-10-15 filing S-8
- 2014-08-08 filing Quarterly report (10-Q)
- 2014-07-24 filing 8-K items 2.02
- 2014-06-02 filing SD
- 2014-05-07 filing Quarterly report (10-Q)
- 2014-05-06 filing 8-K items 5.07
- 2014-04-24 filing 8-K items 2.02
- 2014-03-12 filing Proxy statement
- 2014-03-12 filing Annual report (10-K)
- 2014-02-13 filing 8-K items 5.03
- 2014-01-30 filing 8-K items 2.02
- 2013-12-11 filing CORRESP
- 2013-11-27 filing UPLOAD
- 2013-11-12 filing CORRESP
- 2013-11-06 filing Quarterly report (10-Q)
- 2013-10-29 filing 8-K items 8.01
- 2013-10-24 filing 8-K items 2.02
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-13 (within 30 days) 10-Q filed (UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING)
- 2026-11-03 (within 30 days) 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-10-29 (within 30 days) SC TO-I/A filed (SCHEDULE TO-I/A)
- 2026-10-22 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-05 (older) SC TO-I/A filed (SCHEDULE TO-I/A)
- 2026-09-29 (older) SC TO-I/A filed (SCHEDULE TO-I/A)
- 2026-09-25 (older) SC TO-C filed (SCHEDULE TO-C)
- 2026-09-24 (older) SC TO-C filed (SCHEDULE TO-C)
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:UTMD The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
3 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 706698 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | UTMD / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| LEI (root of the ownership tree) | 5493002R27BBGV8DID60 | id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 5493002R27BBGV8DID60) | GLEIF |
| EIN | 870342734 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000706698 | SEC EDGAR / IRS |
| CUSIP | 917488108 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000706698 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $38,520,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-22 09:46 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $11,286,000 | 2025-12-31 | 10-K, XBRL ProfitLoss | as filed | 2026-11-22 09:46 UTC | Report an error |
| Total assets (at 2025-12-31) | $122,542,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-22 09:46 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $119,268,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-22 09:46 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $85,756,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-22 09:46 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-22 09:46 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-22 09:46 UTC | Report an error |
| State of incorporation | UT | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-22 09:46 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-22 09:46 UTC | Report an error |
| Business address | 7043 S 300 WEST, MIDVALE, UT, 84070 | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-22 09:46 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-22 09:46 UTC | Report an error |
Other filed values
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001096906-26-001742
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $8,621,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0001096906-26-001742 | 2026-11-22 09:46 UTC | Report an error |
| Net income (loss) | $2,787,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0001096906-26-001742 | 2026-11-22 09:46 UTC | Report an error |
| Cash and cash equivalents | $85,202,000 | at 2026-09-30 | 10-Q | 2026-11-13 | 0001096906-26-001742 | 2026-11-22 09:46 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-13 Filing 10-Q filed (UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING)
- 2026-11-03 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-10-29 Filing SC TO-I/A filed (SCHEDULE TO-I/A)
- 2026-10-22 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-05 Filing SC TO-I/A filed (SCHEDULE TO-I/A)
- 2026-09-29 Filing SC TO-I/A filed (SCHEDULE TO-I/A)
- 2026-09-25 Filing SC TO-C filed (SCHEDULE TO-C)
- 2026-09-24 Filing SC TO-C filed (SCHEDULE TO-C)
- 2026-09-24 Filing SC TO-I filed
- 2026-09-17 Filing SC TO-C filed (FORM SC TO-C)
- 2026-08-31 Filing 8-K filed: Item 7.01 Regulation FD disclosure
- 2026-08-14 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 001)
- 2026-08-12 Filing 10-Q filed (UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING)
- 2026-08-03 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 501)
- 2026-07-30 Filing Form 5500 received for plan year ending 2025-12-31 (plan no. 502)
- 2026-07-23 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-05-27 Filing SD filed (UTAH MEDICAL FORM SD)
- 2026-05-12 Filing 10-Q filed (UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING)
- 2026-05-04 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-04-23 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-02 Filing DEF 14A filed (PROXY STATEMENT)
- 2026-03-27 Filing 10-K filed (UTAH MEDICAL PRODUCTS INC - FORM 10-K SEC FILING)
- 2026-01-29 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-11-14 Filing 10-Q filed (UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING)
- 2025-11-04 Filing 8-K filed: Item 5.02 officer or director change; Item 8.01 other event; Item 9.01 exhibits
6 earlier entries
- 2025-10-23 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-08-12 Filing 10-Q filed (UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING)
- 2025-07-24 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 1986-01-01 Record plan effective date: UTAH MEDICAL PRODUCTS, INC. EMPLOYEE WELFARE BENEFIT PLAN
- 1985-01-01 Record plan effective date: UTAH MEDICAL PRODUCTS, INC. 401(K) RETIREMENT PLAN
- 1985-01-01 Record plan effective date: UTAH MEDICAL PRODUCTS, INC. FLEXIBLE BENEFIT PLAN
8-K item text, as filed (excerpts)
- 2026-11-03 8-K Item 8.01, —OTHER EVENTS
On November 3, 2026, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.315 per share is payable on January 5, 2027 to shareholders of record at the close of business on December 17, 2026. A copy of the press release is attached hereto as Exhibit 99.1 the 8-K · retrieved 2026-11-22 09:46 UTC - 2026-10-22 8-K Item 2.02, —RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and nine months ended September 30, 2026 and forward-looking statements relating to 2026 and beyond as presented in a press release dated October 22, 2026. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the… the 8-K · retrieved 2026-11-22 09:46 UTC - 2026-08-31 8-K Item 7.01, Regulation FD Disclosure
On August 31, 2026, Utah Medical Products, Inc. announced that its wholly-owned subsidiary, Femcare Ltd, has purchased all of the common shares of Orion Medical Supplies Ltd of the United Kingdom. A copy of the press release is attached hereto as Exhibit 99.1 the 8-K · retrieved 2026-11-22 09:46 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | BRANDES INVESTMENT PARTNERS, LP | $32,776,399 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
| 2 | BlackRock, Inc. | $14,050,520 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
| 3 | DIMENSIONAL FUND ADVISORS LP | $13,715,681 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $12,127,650 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $9,280,224 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $7,454,824 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
| 7 | Minerva Advisors LLC | $6,457,563 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
| 8 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $5,879,234 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
| 9 | RICE HALL JAMES & ASSOCIATES, LLC | $4,922,620 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
| 10 | STATE STREET CORP | $4,429,595 | 2026-06-30 | SEC 13F filing | 2026-11-22 09:46 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
GLEIF OWNERSHIP TREE · ID TIER11. Subsidiaries
1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).
- Utah Medical Products, Inc. · LEI 5493002R27BBGV8DID60 · root
Exhibit 21 subsidiaries: not held yet.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
3 state and city records carry this company's exact name, from 2 sources. Possible matches only.
Baton Rouge parish businesses (2)
possible match: matched by name only, not merged (2)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchUTAH MEDICAL PRODUCTS · exact name match to 'UTAH MEDICAL PRODUCTS INC' (no other entity shares the name) · sx:brlabiz:00502098 Compare
- possible matchUTAH MEDICAL PRODUCTS · exact name match to 'UTAH MEDICAL PRODUCTS INC' (no other entity shares the name) · sx:brlabiz:00933942 Compare
California payments (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchUTAH MEDICAL PRODUCTS INC · exact legal name · sx:capay:sf:n14db98a6fa52 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/706698.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0000706698. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.